Skip Navigation


NDT Advance Access originally published online on June 2, 2009
Nephrology Dialysis Transplantation 2009 24(10):3157-3162; doi:10.1093/ndt/gfp253
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/10/3157    most recent
gfp253v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sigrist, M. K.
Right arrow Articles by McIntyre, C. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sigrist, M. K.
Right arrow Articles by McIntyre, C. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification

Mhairi K. Sigrist1,2, Adeera Levin2, Lee Er2 and Chris W. McIntyre1

1 School of Graduate Entry Medicine and Health, The University of Nottingham, Derby, DE22 3NE, UK 2 Division of Nephrology, University of British Columbia, St Paul's Hospital, Vancouver, BC, V6Z 1Y6

Correspondence and offprint requests to: Mhairi K. Sigrist; E-mail: msigrist{at}providencehealth.bc.ca



  Abstract

Background. Cardiovascular disease is the leading cause of death in the chronic kidney disease (CKD) population. The mechanisms of vascular damage are not fully understood. The objective of this study was to prospectively investigate the importance of novel mediators of vascular damage, in conjunction with vascular calcification (VC), on survival.

Methods. A total of 134 subjects [60 haemodialysis (HD), 28 peritoneal dialysis (PD) and 46 CKD stage 4] were studied. All survivors completed 40 months of follow-up. VC was measured using multi-slice spiral CT of the superficial femoral artery. Circulating osteoprotegerin (OPG), Fetuin-A and high sensitivity C-reactive protein (hs-CRP) were measured in addition to standard clinical biochemical analysis.

Results. After a 40-month follow-up, 31 patients had died (27 men and 4 women). Of 31 subjects, 31 had evidence of significant VC. The majority of deaths were in the HD group (48%), 36% were PD subjects and 16% were CKD subjects. The outcome of interest was survival at the end of follow-up. Multivariate logistical regression analysis revealed male gender [OR 8.06 (1.34–48.450) P = 0.02], OPG >25 pmol/L [OR 5.31(1.35–20.88) P = 0.02] and hypoalbuminaemia [OR 0.26 (0.12–0.56) P < 0.01], were associated with increased odds of death.

Conclusion. We have previously reported that VC and low albumin predict death in CKD stages 4 and 5 over a 2-year follow-up period. These data show that OPG, independent of CRP, is also associated with a negative outcome. The mechanisms remain to be elucidated; however, it is likely that they are associated with vascular damage through mechanisms in addition to VC.

Keywords: CKD; mortality; osteoprotegerin; vascular calcification

Received for publication: 3.10.08
Accepted in revised form: 4. 5.09


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.